Skip to main content
Top
Published in: Diabetologia 11/2006

01-11-2006 | Article

The impact of family history of diabetes and lifestyle factors on abnormal glucose regulation in middle-aged Swedish men and women

Authors: A. Hilding, A.-K. Eriksson, E. E. Agardh, V. Grill, A. Ahlbom, S. Efendic, C.-G. Östenson

Published in: Diabetologia | Issue 11/2006

Login to get access

Abstract

Aims/hypothesis

We investigated associations between abnormal glucose regulation and family history of diabetes, separately and in combination with lifestyle risk factors.

Subjects and methods

This cross-sectional study comprised 3,128 men and 4,821 women, aged 35–56 years, half with a family history of diabetes. Oral glucose tolerance testing identified subjects with previously undiagnosed prediabetes (IFG, IGT) and type 2 diabetes. Information on lifestyle factors was obtained by questionnaire. Biological interaction was measured with the synergy index.

Results

A family history of diabetes conferred a higher odds ratio (OR) for type 2 diabetes in men (OR=3.1, 95% CI 1.7–5.6) than in women (OR=1.7, 95% CI 1.0–3.0), and the synergy index was 2.8 (95% CI 0.9–9.0), suggesting interaction between a family history of diabetes and sex. For prediabetes and diabetes combined, the synergy index was 1.7 (1.0–2.8). Exposure to only one lifestyle risk factor (obesity, physical inactivity, smoking or low sense of coherence [a psychosocial index]) increased the risk to a similar extent in men and women. Combined exposure to a family history of diabetes and lifestyle-related risk factors had a greater effect on type 2 diabetes than any of these factors alone, especially in men. However, analysis of interaction between a family history of diabetes and the lifestyle factors did not indicate any interaction for diabetes, but did indicate interaction for a family history of diabetes and obesity in women with prediabetes.

Conclusions/interpretation

Our data suggest a more pronounced effect of a family history of diabetes on the risk of type 2 diabetes in men than in women. While both a family history of diabetes and lifestyle risk factors had effects on type 2 diabetes, irrespective of sex, these effects did not appear to interact.
Literature
1.
go back to reference Hamman R (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287–338PubMedCrossRef Hamman R (1992) Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8:287–338PubMedCrossRef
2.
go back to reference Fulton-Kehoe D, Hamman RF, Baxter J, Marshall J (2001) A case–control study of physical activity and non-insulin dependent diabetes mellitus (NIDDM): the San Luis Valley Diabetes Study. Ann Epidemiol 11:320–327PubMedCrossRef Fulton-Kehoe D, Hamman RF, Baxter J, Marshall J (2001) A case–control study of physical activity and non-insulin dependent diabetes mellitus (NIDDM): the San Luis Valley Diabetes Study. Ann Epidemiol 11:320–327PubMedCrossRef
3.
go back to reference Persson, PG, Carlsson S, Svanström L, Östenson CG, Efendic S, Grill V (2000) Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 248:103–110PubMedCrossRef Persson, PG, Carlsson S, Svanström L, Östenson CG, Efendic S, Grill V (2000) Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med 248:103–110PubMedCrossRef
4.
go back to reference Agardh EE, Ahlbom A, Andersson T et al (2003) Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged Swedish women. Diabetes Care 26:719–724PubMed Agardh EE, Ahlbom A, Andersson T et al (2003) Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged Swedish women. Diabetes Care 26:719–724PubMed
5.
go back to reference Poulsen P, Ohm Kyvik K, Vaag A, Beck-Nielsen H (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study. Diabetologia 42:139–145PubMedCrossRef Poulsen P, Ohm Kyvik K, Vaag A, Beck-Nielsen H (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study. Diabetologia 42:139–145PubMedCrossRef
6.
go back to reference McCarthy MI, Froguel P (2002) Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab 283:E217–E225PubMed McCarthy MI, Froguel P (2002) Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab 283:E217–E225PubMed
7.
go back to reference Kuhl J, Hilding A, Östenson CG, Grill V, Efendic S, Båvenholm P (2005) Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity. Diabetologia 48:35–40PubMedCrossRef Kuhl J, Hilding A, Östenson CG, Grill V, Efendic S, Båvenholm P (2005) Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity. Diabetologia 48:35–40PubMedCrossRef
9.
go back to reference Carlsson S, Persson PG, Alvarsson M et al (1998) Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol 148:539–545PubMed Carlsson S, Persson PG, Alvarsson M et al (1998) Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol 148:539–545PubMed
10.
go back to reference Grill V, Persson G, Carlsson S et al (1999) Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects. Diabetologia 42:15–23PubMedCrossRef Grill V, Persson G, Carlsson S et al (1999) Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects. Diabetologia 42:15–23PubMedCrossRef
11.
go back to reference WHO (1985) Diabetes mellitus. Report of the WHO Study Group. WHO Tech Rep Ser 727:1–113 WHO (1985) Diabetes mellitus. Report of the WHO Study Group. WHO Tech Rep Ser 727:1–113
12.
go back to reference Alberti KGMM, Zimmet PZ for the WHO consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef Alberti KGMM, Zimmet PZ for the WHO consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef
13.
go back to reference Antonovsky A (1987) Unrevealing the mystery of health: how people manage stress and stay well. Jossey-Bass, San Francisco Antonovsky A (1987) Unrevealing the mystery of health: how people manage stress and stay well. Jossey-Bass, San Francisco
14.
go back to reference Lundberg O, Nyström Peck M (1995) A simplified way of measuring sense of coherence: experiences from a population survey in Sweden. Eur J Public Health 5:56–69 Lundberg O, Nyström Peck M (1995) A simplified way of measuring sense of coherence: experiences from a population survey in Sweden. Eur J Public Health 5:56–69
15.
go back to reference Rothman KJ (2002) Epidemiology: an introduction. Oxford University Press, New York Rothman KJ (2002) Epidemiology: an introduction. Oxford University Press, New York
16.
go back to reference Ahlbom A, Alfredsson L (2005) Interaction: a word with two meanings creates confusion. Eur J Epidemiol 20:563–564PubMedCrossRef Ahlbom A, Alfredsson L (2005) Interaction: a word with two meanings creates confusion. Eur J Epidemiol 20:563–564PubMedCrossRef
17.
go back to reference Rothman KJ (1986) Modern epidemiology. Little, Brown, Boston Rothman KJ (1986) Modern epidemiology. Little, Brown, Boston
18.
go back to reference Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452–456PubMed Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452–456PubMed
19.
go back to reference Tilburg J, Haeften TW, Pearson P, Wijmenga C (2001) Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet 38:569–578PubMedCrossRef Tilburg J, Haeften TW, Pearson P, Wijmenga C (2001) Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet 38:569–578PubMedCrossRef
20.
go back to reference Ko GTC, Chan JCN, Tsang LWW, Yeung VTF, Chow CC, Cockram CS (2000) Outcomes of screening for diabetes in high-risk Hong Kong Chinese subjects. Diabetes Care 23:1290–1294PubMed Ko GTC, Chan JCN, Tsang LWW, Yeung VTF, Chow CC, Cockram CS (2000) Outcomes of screening for diabetes in high-risk Hong Kong Chinese subjects. Diabetes Care 23:1290–1294PubMed
21.
go back to reference Lidfeldt J, Nerbrand C, Samsioe G, Scherstén B, Agardh CD (2001) A screening procedure detecting high-yield candidates for OGTT. The Womens’ Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women. Eur J Epidemiol 17:943–951PubMedCrossRef Lidfeldt J, Nerbrand C, Samsioe G, Scherstén B, Agardh CD (2001) A screening procedure detecting high-yield candidates for OGTT. The Womens’ Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women. Eur J Epidemiol 17:943–951PubMedCrossRef
22.
go back to reference Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N (2003) Relationship between development of diabetes and family history by gender in Japanese-Americans. Diabetes Res Clin Pract 61:109–115PubMedCrossRef Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N (2003) Relationship between development of diabetes and family history by gender in Japanese-Americans. Diabetes Res Clin Pract 61:109–115PubMedCrossRef
23.
go back to reference Morris RD, Limm DL, Hartz J, Kalkhoff RK, Rimm AA (1989) Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women. Am J Epidemiol 130:112–121PubMed Morris RD, Limm DL, Hartz J, Kalkhoff RK, Rimm AA (1989) Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women. Am J Epidemiol 130:112–121PubMed
24.
go back to reference van Dam RM, Boer JMA, Feskens EJM, Seidell JC (2001) Parental history of diabetes mellitus modifies the association between abdominal adiposity and hyperglycemia. Diabetes Care 24:1454–1459PubMed van Dam RM, Boer JMA, Feskens EJM, Seidell JC (2001) Parental history of diabetes mellitus modifies the association between abdominal adiposity and hyperglycemia. Diabetes Care 24:1454–1459PubMed
25.
go back to reference Speakman JR (2004) Obesity: the integrated roles of environment and genetics. J Nutr 134:2090S–2105SPubMed Speakman JR (2004) Obesity: the integrated roles of environment and genetics. J Nutr 134:2090S–2105SPubMed
26.
go back to reference Weijnen CF, Rich SS, Meigs JB, Krolewski AS, Warram JH (2002) Risk of diabetes in siblings of index cases with type 2 diabetes: implications of genetic studies. Diabetic Med 19:41–50PubMedCrossRef Weijnen CF, Rich SS, Meigs JB, Krolewski AS, Warram JH (2002) Risk of diabetes in siblings of index cases with type 2 diabetes: implications of genetic studies. Diabetic Med 19:41–50PubMedCrossRef
27.
go back to reference Godsland IF (1996) The influence of female sex steroids on glucose metabolism and insulin action. J Intern Med 240(Suppl 738):1–60 Godsland IF (1996) The influence of female sex steroids on glucose metabolism and insulin action. J Intern Med 240(Suppl 738):1–60
28.
go back to reference Rossi R, Origliani G, Modena MG (2004) Transdermal 17-β-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women. Diabetes Care 27:645–649PubMed Rossi R, Origliani G, Modena MG (2004) Transdermal 17-β-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women. Diabetes Care 27:645–649PubMed
29.
go back to reference Kanaya AM, Herrington D, Vittinghoff E et al (2003) Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestrin Replacement Study. Ann Intern Med 138:1–9PubMed Kanaya AM, Herrington D, Vittinghoff E et al (2003) Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestrin Replacement Study. Ann Intern Med 138:1–9PubMed
30.
go back to reference Wu SI, Chou P, Tsai ST (2001) The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54:117–120PubMedCrossRef Wu SI, Chou P, Tsai ST (2001) The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54:117–120PubMedCrossRef
31.
go back to reference Fujimoto WY, Bergstrom RW, Boyko EJ et al (1994) Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington. Diabetes Res Clin Pract 24(Suppl):S43–S52CrossRef Fujimoto WY, Bergstrom RW, Boyko EJ et al (1994) Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington. Diabetes Res Clin Pract 24(Suppl):S43–S52CrossRef
32.
go back to reference Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRef Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRef
33.
go back to reference Facchini FS (1998) Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 21:2190PubMed Facchini FS (1998) Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 21:2190PubMed
34.
go back to reference Hua NW, Stoohs RA, Facchini FS (2001) Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 86:515–519PubMed Hua NW, Stoohs RA, Facchini FS (2001) Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 86:515–519PubMed
35.
go back to reference Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291:711–717PubMedCrossRef Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291:711–717PubMedCrossRef
36.
go back to reference Gu HF, Efendic S, Nordman S et al (2004) Quantitative trait loci near the insulin-degrading enzyme (IDF) gene contribute to variation in plasma insulin levels. Diabetes 53:2137–2142PubMed Gu HF, Efendic S, Nordman S et al (2004) Quantitative trait loci near the insulin-degrading enzyme (IDF) gene contribute to variation in plasma insulin levels. Diabetes 53:2137–2142PubMed
37.
go back to reference Nordman S, Ding B, Östenson CG et al (2005) Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Exp Clin Endocrinol Diabetes 205:282–287CrossRef Nordman S, Ding B, Östenson CG et al (2005) Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Exp Clin Endocrinol Diabetes 205:282–287CrossRef
38.
go back to reference Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459–469PubMed Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459–469PubMed
39.
go back to reference Zoico E, Di Francesco V, Mazzali G et al (2004) Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol 59A:935–939 Zoico E, Di Francesco V, Mazzali G et al (2004) Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol 59A:935–939
40.
go back to reference Diez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300PubMedCrossRef Diez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300PubMedCrossRef
41.
go back to reference Tripathy D, Lindholm E, Isomaa B, Saloranta C, Tuomi T, Groop L (2003) Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetes proband. Am J Physiol Endocrinol Metab 285:E1297–E1303PubMed Tripathy D, Lindholm E, Isomaa B, Saloranta C, Tuomi T, Groop L (2003) Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetes proband. Am J Physiol Endocrinol Metab 285:E1297–E1303PubMed
Metadata
Title
The impact of family history of diabetes and lifestyle factors on abnormal glucose regulation in middle-aged Swedish men and women
Authors
A. Hilding
A.-K. Eriksson
E. E. Agardh
V. Grill
A. Ahlbom
S. Efendic
C.-G. Östenson
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0402-5

Other articles of this Issue 11/2006

Diabetologia 11/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine